{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T16:20:10Z","timestamp":1757780410968,"version":"3.40.5"},"reference-count":47,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.endien.2024.11.010","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T22:52:00Z","timestamp":1732056720000},"page":"436-446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Automated insulin delivery systems in the treatment of diabetes: Benefits, challenges, and practical considerations in pediatric patients"],"prefix":"10.1016","volume":"71","author":[{"given":"Patricia","family":"Enes Romero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"G\u00fcemes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca","family":"Guijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel \u00c1.","family":"Martos-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Pozo Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5826-0276","authenticated-orcid":false,"given":"Jes\u00fas","family":"Argente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.endien.2024.11.010_bib0005","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/pedi.13455","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes","volume":"23","author":"de Bock","year":"2022","journal-title":"Pediatr Diabetes"},{"issue":"5","key":"10.1016\/j.endien.2024.11.010_bib0010","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.2337\/dc20-1674","article-title":"Glycemic outcome associated with insulin pump and glucose sensor use in children and adolescents with type 1 diabetes. Data from the international pediatric registry SWEET","volume":"44","author":"Cardona-Hernandez","year":"2021","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.endien.2024.11.010_bib0015","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1089\/dia.2023.0320","article-title":"Longitudinal trends in glycemic outcomes and technology use for over 48,000 people with type 1 diabetes (2016-2022) from the T1D exchange quality improvement collaborative","volume":"25","author":"Ebekozien","year":"2023","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"10.1016\/j.endien.2024.11.010_bib0020","doi-asserted-by":"crossref","first-page":"660","DOI":"10.2337\/dc23-1317","article-title":"Demographic, clinical, management, and outcome characteristics of 8,004 young children with type 1 diabetes","volume":"47","author":"Sandy","year":"2024","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.endien.2024.11.010_bib0025","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","article-title":"Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study","volume":"10","author":"Gregory","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.endien.2024.11.010_bib0030","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1210\/endrev\/bnac022","article-title":"Consensus recommendations for the use of automated insulin delivery technologies in clinical practice","volume":"44","author":"Phillip","year":"2023","journal-title":"Endocr Rev"},{"issue":"10270","key":"10.1016\/j.endien.2024.11.010_bib0035","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(20)32514-9","article-title":"A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial","volume":"397","author":"Bergenstal","year":"2021","journal-title":"Lancet Lond Engl"},{"issue":"4","key":"10.1016\/j.endien.2024.11.010_bib0040","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2337\/dc20-2250","article-title":"Improved glycemic outcomes with Medtronic MiniMed advanced hybrid closed-loop delivery: results from a randomized crossover trial comparing automated insulin delivery with predictive low glucose suspend in people with type 1 diabetes","volume":"44","author":"Collyns","year":"2021","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.endien.2024.11.010_bib0045","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1089\/dia.2020.0572","article-title":"Closed-loop insulin therapy improves glycemic control in adolescents and young adults: outcomes from the international diabetes closed-loop trial","volume":"23","author":"Isganaitis","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"9","key":"10.1016\/j.endien.2024.11.010_bib0050","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJMoa2004736","article-title":"A randomized trial of closed-loop control in children with type 1 diabetes","volume":"383","author":"Breton","year":"2020","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.endien.2024.11.010_bib0055","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa2210834","article-title":"Trial of hybrid closed-loop control in young children with type 1 diabetes","volume":"388","author":"Wadwa","year":"2023","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.endien.2024.11.010_bib0060","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1016\/S2589-7500(22)00020-6","article-title":"Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial","volume":"4","author":"Ware","year":"2022","journal-title":"Lancet Digit Health"},{"issue":"3","key":"10.1016\/j.endien.2024.11.010_bib0065","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMoa2111673","article-title":"Randomized trial of closed-loop control in very young children with type 1 diabetes","volume":"386","author":"Ware","year":"2022","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.endien.2024.11.010_bib0070","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1089\/dia.2022.0313","article-title":"MiniMed 780GTM in 2- to 6-year-old children: safety and clinical outcomes after the first 12 weeks","volume":"25","author":"Pulkkinen","year":"2023","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.endien.2024.11.010_bib0075","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12902-022-00996-7","article-title":"Glycemic outcomes of Advanced Hybrid Closed Loop system in children and adolescents with Type 1 Diabetes, previously treated with Multiple Daily Injections (MiniMed 780G system in T1D individuals, previously treated with MDI)","volume":"22","author":"Petrovski","year":"2022","journal-title":"BMC Endocr Disord"},{"issue":"9","key":"10.1016\/j.endien.2024.11.010_bib0080","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1089\/dia.2023.0123","article-title":"Glycemic outcomes during early use of the MiniMedTM 780G advanced hybrid closed-loop system with guardian\u2122 4 sensor","volume":"25","author":"Cordero","year":"2023","journal-title":"Diabetes Technol Ther"},{"issue":"10","key":"10.1016\/j.endien.2024.11.010_bib0085","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1056\/NEJMoa2203496","article-title":"Closed-loop therapy and preservation of C-peptide secretion in type 1 diabetes","volume":"387","author":"Boughton","year":"2022","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.endien.2024.11.010_bib0090","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/dom.14714","article-title":"Comparison of MiniMed 780G system performance in users aged younger and older than 15 years: evidence from 12 870 real-world users","volume":"24","author":"Arrieta","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.endien.2024.11.010_bib0095","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.766314","article-title":"Six-month effectiveness of advanced vs. standard hybrid closed-loop system in children and adolescents with type 1 diabetes mellitus","volume":"12","author":"Tornese","year":"2021","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.endien.2024.11.010_bib0100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/dia.2021.0203","article-title":"Real-world performance of the MiniMedTM 780G system: first report of outcomes from 4120 users","volume":"24","author":"Silva","year":"2022","journal-title":"Diabetes Technol Ther"},{"issue":"9","key":"10.1016\/j.endien.2024.11.010_bib0105","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/dia.2021.0097","article-title":"One year real-world use of the control-IQ advanced hybrid closed-loop technology","volume":"23","author":"Breton","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"10.1016\/j.endien.2024.11.010_bib0110","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1089\/dia.2020.0388","article-title":"Real-world patient-reported outcomes and glycemic results with initiation of control-IQ technology","volume":"23","author":"Pinsker","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"10.1016\/j.endien.2024.11.010_bib0115","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.2337\/dc13-2644","article-title":"Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial","volume":"37","author":"Hovorka","year":"2014","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.endien.2024.11.010_bib0120","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1089\/dia.2022.0491","article-title":"MiniMed 780G six-month use in children and adolescents with type 1 diabetes: clinical targets and predictors of optimal glucose control","volume":"25","author":"Lombardo","year":"2023","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"10.1016\/j.endien.2024.11.010_bib0125","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14863","article-title":"Real-world prospective observational single-centre study: hybrid closed loop improves HbA1c, time-in-range and quality of life for children, young people and their carers","volume":"39","author":"Ng","year":"2022","journal-title":"Diabet Med J Br Diabet Assoc"},{"issue":"6","key":"10.1016\/j.endien.2024.11.010_bib0130","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.2337\/dc22-2046","article-title":"Safety of real-life usage of advanced hybrid closed-loop system MiniMed 780G in children with type 1 diabetes younger than 7 years old","volume":"46","author":"Tornese","year":"2023","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.endien.2024.11.010_bib0135","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/dia.2023.0508","article-title":"Clinical outcomes with MiniMedTM 780G advanced hybrid closed-loop therapy in 2- to 6-year-old children with type 1 diabetes","volume":"26","author":"Abraham","year":"2024","journal-title":"Diabetes Technol Ther"},{"issue":"S3","key":"10.1016\/j.endien.2024.11.010_bib0140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1089\/dia.2023.0433","article-title":"Celebrating the data from 100,000 real-world users of the MiniMedTM 780G system in Europe, Middle East, and Africa collected over 3 years: from data to clinical evidence","volume":"26","author":"Choudhary","year":"2024","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"10.1016\/j.endien.2024.11.010_bib0145","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3826","article-title":"Time in tight range in children and adolescents with type 1 diabetes: a cross-sectional observational single centre study evaluating efficacy of new advanced technologies","volume":"40","author":"Schiaffini","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.endien.2024.11.010_bib0150","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1099024","article-title":"One-year follow-up comparison of two hybrid closed-loop systems in Italian children and adults with type 1 diabetes","volume":"14","author":"Bassi","year":"2023","journal-title":"Front Endocrinol"},{"issue":"7","key":"10.1016\/j.endien.2024.11.010_bib0155","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00592-022-01886-z","article-title":"Comparison of two advanced hybrid closed loop in a pediatric population with type 1 diabetes: a real-life observational study","volume":"59","author":"Schiaffini","year":"2022","journal-title":"Acta Diabetol"},{"issue":"2","key":"10.1016\/j.endien.2024.11.010_bib0160","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2337\/dc23-1355","article-title":"A multicenter prospective evaluation of the benefits of two advanced hybrid closed-loop systems in glucose control and patient-reported outcomes in a real-world setting","volume":"47","author":"Beato-V\u00edbora","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endien.2024.11.010_bib0165","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1283181","article-title":"Are all HCL systems the same? Long term outcomes of three HCL systems in children with type 1 diabetes: real-life registry-based study","volume":"14","author":"Santova","year":"2023","journal-title":"Front Endocrinol"},{"issue":"12","key":"10.1016\/j.endien.2024.11.010_bib0170","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1001\/jamapediatrics.2021.3965","article-title":"Effect of a hybrid closed-loop system on glycemic and psychosocial outcomes in children and adolescents with type 1 diabetes: a randomized clinical trial","volume":"175","author":"Abraham","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"1","key":"10.1016\/j.endien.2024.11.010_bib0175","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00592-021-01789-5","article-title":"Improved technology satisfaction and sleep quality with Medtronic MiniMed\u00ae Advanced Hybrid Closed-Loop delivery compared to predictive low glucose suspend in people with Type 1 Diabetes in a randomized crossover trial","volume":"59","author":"Wheeler","year":"2022","journal-title":"Acta Diabetol"},{"issue":"12","key":"10.1016\/j.endien.2024.11.010_bib0180","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1089\/dia.2021.0153","article-title":"Lived experience of advanced hybrid closed-loop versus hybrid closed-loop: patient-reported outcomes and perspectives","volume":"23","author":"Hood","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"10.1016\/j.endien.2024.11.010_bib0185","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.2337\/dc21-1778","article-title":"Improvements in parental sleep, fear of hypoglycemia, and diabetes distress with use of an advanced hybrid closed-loop system","volume":"45","author":"Cobry","year":"2022","journal-title":"Diabetes Care"},{"issue":"Supplement_1","key":"10.1016\/j.endien.2024.11.010_bib0190","first-page":"S258","article-title":"14. Children and adolescents: standards of care in diabetes\u20142024","volume":"47","year":"2023","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.endien.2024.11.010_bib0195","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15078","article-title":"UK\u2019s Association of British Clinical Diabetologist\u2019s Diabetes Technology Network (ABCD-DTN): best practice guide for hybrid closed-loop therapy","volume":"40","author":"Griffin","year":"2023","journal-title":"Diabet Med J Br Diabet Assoc"},{"issue":"5","key":"10.1016\/j.endien.2024.11.010_bib0200","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2337\/dc23-1581","article-title":"Time in tight glucose range in type 1 diabetes: predictive factors and achievable targets in real-world users of the MiniMed 780G system","volume":"47","author":"Casta\u00f1eda","year":"2024","journal-title":"Diabetes Care"},{"issue":"S3","key":"10.1016\/j.endien.2024.11.010_bib0205","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/dia.2023.0446","article-title":"A peek under the hood: explaining the MiniMedTM 780G algorithm with meal detection technology","volume":"26","author":"Grosman","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.endien.2024.11.010_bib0210","unstructured":"FAQs - MiniMed\u2122 780G System Support | Medtronic [Internet]. 2024 [Accessed 1 July 2024]. Available from: https:\/\/www.medtronicdiabetes.com\/customer-support\/minimed-780g-system-support\/faq."},{"issue":"12","key":"10.1016\/j.endien.2024.11.010_bib0215","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1089\/dia.2023.0308","article-title":"Therapy settings associated with optimal outcomes for t:slim X2 with control-IQ technology in real-world clinical care","volume":"25","author":"Messer","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.endien.2024.11.010_bib0220","unstructured":"YpsoPump with mylife Loop - mylife Diabetescare \u2013 Espa\u00f1a [Internet]. [Accessed 2 July 2024]. Available from: https:\/\/www.mylife-diabetescare.com\/es-ES\/mylife-loop.html."},{"key":"10.1016\/j.endien.2024.11.010_bib0225","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.846137","article-title":"Technologies for type 1 diabetes and contact dermatitis: therapeutic tools and clinical outcomes in a cohort of pediatric patients","volume":"13","author":"Passanisi","year":"2022","journal-title":"Front Endocrinol"},{"issue":"S3","key":"10.1016\/j.endien.2024.11.010_bib0230","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1089\/dia.2023.0429","article-title":"Twelve-month follow-up from a randomized controlled trial of simplified meal announcement versus precise carbohydrate counting in adolescents with type 1 diabetes using the MiniMedTM 780G advanced hybrid closed-loop system","volume":"26","author":"Petrovski","year":"2024","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"10.1016\/j.endien.2024.11.010_bib0235","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.2337\/dc21-2643","article-title":"Carbohydrate tolerance threshold for unannounced snacks in children and adolescents with type 1 diabetes using an advanced hybrid closed-loop system","volume":"45","author":"Tornese","year":"2022","journal-title":"Diabetes Care"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018024001197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018024001197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T20:49:16Z","timestamp":1732999756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530018024001197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2530018024001197"],"URL":"https:\/\/doi.org\/10.1016\/j.endien.2024.11.010","relation":{},"ISSN":["2530-0180"],"issn-type":[{"type":"print","value":"2530-0180"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Automated insulin delivery systems in the treatment of diabetes: Benefits, challenges, and practical considerations in pediatric patients","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endien.2024.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.endinu.2024.07.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of SEEN and SED.","name":"copyright","label":"Copyright"}]}}